Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i> -Mutant Ovarian Cancer ModelsHyoung Kim, Fiona Simpkins|Clinical Cancer Research|2016Cited by 292